First case of typical Old World cutaneous leishmaniasis treated with miltefosine

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Dermatology

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-4632.2007.03153.xPMID 17442078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.

  2005cited by this paper
• Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.

  2005cited by this paper
• Miltefosine for new world cutaneous leishmaniasis.

  2004cited by this paper
• Patents and access to drugs in developing countries: an ethical analysis.

  2004cited by this paper
• Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.

  2004cited by this paper
• Diagnosis of cutaneous leishmaniasis

  2003cited by this paper
• Current treatment approaches to leishmaniasis

  2003cited by this paper
• Oral miltefosine for Indian visceral leishmaniasis.

  2002cited by this paper
• Practical Guide for the Treatment of Leishmaniasis

  1998cited by this paper
• Heterogeneity of cutaneous leishmaniasis with emphasis on the Old World.

  1993cited by this paper

• Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.

  2021cites this paper
• Current and emerging medications for the treatment of leishmaniasis

  2019cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• Interventions for Old World cutaneous leishmaniasis.

  2017cites this paper
• Infections associated with adventure travel: A systematic review

  2017cites this paper
• Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature

  2016cites this paper
• Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.

  2015cites this paper
• An update on pharmacotherapy for leishmaniasis

  2015cites this paper
• Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis

  2013cites this paper
• Clinical pharmacology in leishmaniasis: treatment optimization of a neglected disease

  2013cites this paper
• Genetic Polymorphisms and Drug Susceptibility in Four Isolates of Leishmania tropica Obtained from Canadian Soldiers Returning from Afghanistan

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Clinical pharmacology in leishmaniasis : treatment optimization of a neglected disease

  2012cites this paper
• Giardia lamblia: a new target for miltefosine.

  2012cites this paper
• Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine

  2011cites this paper
• Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany

  2011cites this paper
• A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis

  2010cites this paper
• Wirksamkeit und Verträglichkeit des Raft-Interventionstherapeutikums Miltefosin bei der Behandlung der kutanen Mastozytose

  2010cites this paper
• Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.

  2010cites this paper
• Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica

  2009cites this paper
• S1‐Leitlinie Diagnostik und Therapie der kutanen und mukokutanen Leishmaniasis in Deutschland

  2009cites this paper
• Treatment of leishmaniasis with miltefosine: 2008 status

  2008cites this paper
• Pharmacokinetics of Miltefosine in Old World Cutaneous Leishmaniasis Patients

  2008cites this paper
• Structure, function, and mechanism of human MIF and parasitic orthologs

  2008cites this paper